...
首页> 外文期刊>Biotechnology Law Report >In Re Jeffrey Hubbell, Jason Schense, Andreas Ziseh, and Heike Hall (United States Court of Appeals for the Federal Circuit)
【24h】

In Re Jeffrey Hubbell, Jason Schense, Andreas Ziseh, and Heike Hall (United States Court of Appeals for the Federal Circuit)

机译:在Re Jeffrey Hubbell,Jason Schense,Andreas Ziseh和Heike Hall(美国联邦巡回上诉法院)中

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Jeffrey Hubbell, Jason Schense, Andreas Zisch, and Heike Hall are the named inventors on U.S. Patent Application No. 10/650,509 ("the '509 application"). The examiner rejected all of the pending claims-—claims 1-5,7, 9-14, 16-22, 26-30, 34, and 35—for obviousness-type double patenting over several patents, including U.S. Patent No. 7,601,685 ("the '685 patent"). Hubbell appeals from the decision of the Board of Patent Appeals and Interferences ("the Board") affirming the examiner's final rejectionwith respect to the '685 patent. Ex parte Jeffrey Hubbell, Jason Schense, Andreas Zisch, and Heike Hall, No. 2010-004497, 2011 Pat. App. LEXIS 19847 (B.P.A.I. May 20, 201 ){"Board Decision"). Because the Board did not err in concluding that the pendingclaims were barred under the doctrine of obviousness-type double patenting, we affirm.
机译:Jeffrey Hubbell,Jason Schense,Andreas Zisch和Heike Hall是美国专利申请10 / 650,509(“'509申请”)的指定发明人。审查员拒绝了所有待决的权利要求-权利要求1-5,7、9-14、16-22、26-30、34和35-对包括美国专利号7,601,685在内的多项专利进行了明显类型的双重专利保护(“'685专利”)。 Hubbell对专利上诉和干扰委员会(以下简称“委员会”)的裁决提出上诉,该裁决确认了审查员对'685专利的最终驳回。单方Jeffrey Hubbell,Jason Schense,Andreas Zisch和Heike Hall,2010-004497号,2011年。应用程式LEXIS 19847(B.P.A.I.,201年5月20日){“董事会决议”)。我们确认,因为委员会不会得出结论,即悬而未决的主张已被禁止在显而易见性类型的双重专利保护原则下进行,所以我们肯定。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号